Castle Biosciences, Inc. · NASDAQ:CSTL

Juvenal Tobin W sold 1,301 Castle Biosciences, Inc. shares (Form 4)

Traded Nov 24, 2025 · Filed Aug 6, 2026

On Nov 24, 2025, Juvenal Tobin W (Chief Commercial Officer) sold 1,301 Castle Biosciences, Inc. shares at US$38.39 for US$49,945 under a trading plan, leaving 77,694 shares. Filed Aug 6, 2026 (Form 4).

Sold
1,301 shares
Price
US$38.39
Value
US$49,945
Holding after
77,694 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 24, 2025Common StockSale1,301US$38.3977,694Direct

Source

View original at SEC

Related